Certified by Founder Lodge
Brandon Capital
Australia - Melbourne, Victoria
INVESTOR
1 Disclosed Funding Rounds $58,462,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK. Through collabor
| Company | Date | Round | Raised |
|---|---|---|---|
 Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
 AstronauTx |
October, 09 ,2023 | Series A | $58,462,000 |
 NRG Therapeutics |
September, 09 ,2025 | Series B | $67,835,242 |
 Pathios Therapeutics |
April, 19 ,2024 | Series B | $25,000,000 |
 Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
 Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
 CatalYm GmbH |
July, 16 ,2024 | Series D | $150,000,000 |
| Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
| NRG Therapeutics |
September, 09 ,2025 | Series B | $67,835,242 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
